With respect to solid tumors, MCL-1 inhibition was effective in a subset of SCLC cell lines with high MCL-1 and low BCL-XL expression, including in a patient-derived cell line xenograft model in vivo [168]. The gene discussed is BCL2L1; the disease is small cell lung carcinoma.